Position in ALNY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,044,334
+$50,030 QoQ
Shares Held
9,201
+22.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.19563090968373.ToString("F0")%
Shared 0.ToString("F0")%
None 99.80436909031627.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NewEdge Wealth, LLC holds $20,244,273 across 19 Biotechnology names. ALNY ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,788 | $4,370,733 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
9,201 | $3,044,334 | |
| 3 | BHVN |
Biohaven Ltd.
|
246,503 | $2,085,415 | |
| 4 | EXEL |
Exelixis, Inc.
|
42,331 | $1,815,576 | |
| 5 | INVA |
Innoviva, Inc.
|
77,134 | $1,797,222 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
27,887 | $1,124,124 | |
| 7 | NVAX |
Novavax Inc
|
130,000 | $1,058,200 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
21,856 | $711,194 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,044,334 | 9,201 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,994,304 | 7,530 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,644,808 | 7,993 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $294,133 | 902 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||